Search

Your search keyword '"Vieito, Maria"' showing total 7 results
Start Over Author "Vieito, Maria" Publisher oxford university press (oup)
7 results on '"Vieito, Maria"'

1. RTID-03. A PHASE 1/2 STUDY OF THE WEE1 INHIBITOR DEBIO 0123 IN COMBINATION WITH TEMOZOLOMIDE +- RADIOTHERAPY IN ADULTS WITH RECURRENT OR NEWLY DIAGNOSED GLIOBLASTOMA

Author

Roth, Patrick, primary, Papadopoulos, Kyriakos P, additional, Vieito, Maria, additional, Yang, Jonathan, additional, Majd, Nazanin, additional, Sepúlveda, Juan, additional, Schaff, Lauren, additional, Moreno, Victor, additional, Pérez -Larraya, Jaime Gállego, additional, Micallef, Sandrine, additional, Bellon, Anne, additional, Omar, Mokhtar, additional, Imedio, Esteban Rodrigo, additional, Piggott, Luke, additional, Rodriguez-Freixinos, Victor, additional, and Rodon, Jordi, additional

Published
2023
Full Text
View/download PDF

2. CTIM-25. EO2401 PEPTIDE IMMUNOTHERAPY + NIVOLUMAB +/- BEVACIZUMAB IN FIRST RECURRENT GLIOBLASTOMA: THE PHASE 1/2 EOGBM1-18/ROSALIE STUDY (NCT04116658)

Author

Reardon, David, primary, Idbaih, Ahmed, additional, Vieito, Maria, additional, Ghiringhelli, François, additional, Stradella, Agostina, additional, Tabatabai, Ghazaleh, additional, Burger, Michael C, additional, Mildenberger, Iris, additional, Herrlinger, Ulrich, additional, Wen, Patrick, additional, Touat, Mehdi, additional, Wick, Antje, additional, González, Macarena, additional, Hervieu, Alice, additional, GilMartin, Marta, additional, Renovanz, Mirjam, additional, Gouttefangeas, Cécile, additional, Maia, Ana, additional, Bonny, Christophe, additional, Paillarse, Jean-Michel, additional, Chêne, Laurent, additional, Fagerberg, Jan, additional, and Wick, Wolfgang, additional

Published
2023
Full Text
View/download PDF

3. CTIM-17. EO2401 THERAPEUTIC VACCINE FOR PATIENTS WITH RECURRENT GLIOBLASTOMA: PHASE 1/2 ROSALIE STUDY (NCT04116658)

Author

Reardon, David A, primary, Idbaih, Ahmed, additional, Vieito, Maria, additional, Tabatabai, Ghazaleh, additional, Stradella, Agostina, additional, Ghiringhelli, François, additional, Burger, Michael C, additional, Mildenberger, Iris, additional, González, Macarena, additional, Hervieu, Alice, additional, Martin, Marta Gil, additional, Renovanz, Mirjam, additional, Touat, Mehdi, additional, Wen, Patrick Y, additional, Wick, Antje, additional, Gouttefangeas, Cécile, additional, Maia, Ana, additional, Bonny, Christophe, additional, Fagerberg, Jan, additional, and Wick, Wolfgang, additional

Published
2022
Full Text
View/download PDF

4. CTNI-21. TROTABRESIB (CC-90010) IN COMBINATION WITH CONCOMITANT TEMOZOLOMIDE PLUS RADIOTHERAPY AND ADJUVANT TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA: UPDATED RESULTS FROM A PHASE 1B/2 STUDY

Author

Vieito, Maria, primary, Sepulveda, Juan Manuel, additional, Moreno, Victor, additional, de Vos, Filip, additional, Geurts, Marjolein, additional, Lorenzi, Elena, additional, Macchini, Marina, additional, van den Bent, Martin, additional, Del Conte, Gianluca, additional, Martín-Soberón, Maria Cruz, additional, Brandal, Petter, additional, Garcia, Maria Martinez, additional, Amoroso, Barbara, additional, Sanchez-Perez, Tania, additional, Zuraek, Marlene, additional, Hanna, Bishoy, additional, Filvaroff, Ellen, additional, Chang, Henry, additional, Parro, Marina Arias, additional, Wei, Xin, additional, Liu, Yu, additional, Nikolova, Zariana, additional, and Simonelli, Matteo, additional

Published
2022
Full Text
View/download PDF

5. Olutasidenib (FT-2102) in patients with relapsed or refractory IDH1-mutant glioma: A multicenter, open-label, phase Ib/II trial

Author

de la Fuente, Macarena I, primary, Colman, Howard, additional, Rosenthal, Mark, additional, Van Tine, Brian A, additional, Levacic, Danijela, additional, Walbert, Tobias, additional, Gan, Hui K, additional, Vieito, Maria, additional, Milhem, Mohammed M, additional, Lipford, Kathryn, additional, Forsyth, Sanjeev, additional, Guichard, Sylvie M, additional, Mikhailov, Yelena, additional, Sedkov, Alexander, additional, Brevard, Julie, additional, Kelly, Patrick F, additional, Mohamed, Hesham, additional, and Monga, Varun, additional

Published
2022
Full Text
View/download PDF

6. Trotabresib (CC-90010) in combination with adjuvant temozolomide or concomitant temozolomide plus radiotherapy in patients with newly diagnosed glioblastoma

Author

Vieito, Maria, primary, Simonelli, Matteo, additional, de Vos, Filip, additional, Moreno, Victor, additional, Geurts, Marjolein, additional, Lorenzi, Elena, additional, Macchini, Marina, additional, van den Bent, Martin J, additional, Del Conte, Gianluca, additional, de Jonge, Maja, additional, Martín-Soberón, Maria Cruz, additional, Amoroso, Barbara, additional, Sanchez-Perez, Tania, additional, Zuraek, Marlene, additional, Hanna, Bishoy, additional, Aronchik, Ida, additional, Filvaroff, Ellen, additional, Chang, Henry, additional, Mendez, Cristina, additional, Arias Parro, Marina, additional, Wei, Xin, additional, Nikolova, Zariana, additional, and Sepulveda, Juan Manuel, additional

Published
2022
Full Text
View/download PDF

7. CTNI-51. ADJUVANT TROTABRESIB, A REVERSIBLE POTENT BROMODOMAIN AND EXTRATERMINAL INHIBITOR, PLUS TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA: INTERIM RESULTS FROM A PHASE 1B DOSE-FINDING STUDY

Author

Vieito, Maria, primary, Simonelli, Matteo, additional, de Vos, Filip, additional, Moreno, Victor, additional, Geurts, Marjolein, additional, Lorenzi, Elena, additional, Macchini, Marina, additional, van den Bent, Martin, additional, Del Conte, Gianluca, additional, de Jonge, Maja, additional, Amoroso, Barbara, additional, Sanchez-Perez, Tania, additional, Zuraek, Marlene, additional, Hanna, Bishoy, additional, Aronchik, Ida, additional, Filvaroff, Ellen, additional, Mendez, Cristina, additional, Wei, Xin, additional, Nikolova, Zariana, additional, and Sepulveda, Juan Manuel, additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results